Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. Sabahaddin Akman, owner of the Turkish firm Ozay Pharmaceuticals, pleaded guilty in the U.S. District Court for the Eastern District of Missouri, to smuggling counterfeit cancer drugs including multiple shipments of Altuzan, the Turkish version of bevacizumab (Avastin, Genentech).
The drugs did not meet FDA standards and had not been approved for distribution in the United States. The FDA’s Office of Criminal Investigations organized an international investigation that led to Akman’s arrest in Puerto Rico in January 2014. The investigation identified Akman and his company as a source of Altuzan.
Related Posts
Romania-Rep. of Moldova joint customs operations reduce cigarette smuggling in north-eastern Romania
The Romania-Republic of Moldova joint customs operations led to a decrease in the...
Microsoft, Alibaba collaborate to take on counterfeit software products
Tech giant Microsoft has collaborated with Chinese online retailer Alibaba Group...
Foreign cigarettes: A challenge for Assam Police
GUWAHATI: Guwahati has turned into a hub of foreign cigarettes in India. Foreign...
Black market tobacco now 14.5 per cent of all consumption, Illicit Tobacco in Australia report shows
THE BILLION dollar illicit tobacco black market has hit a record high as...